wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33939624-18219ACE-E9BF-4F9C-87C4-5BE27620D95A
Q33939624-18219ACE-E9BF-4F9C-87C4-5BE27620D95A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33939624-18219ACE-E9BF-4F9C-87C4-5BE27620D95A
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AML.
P2860
Q33939624-18219ACE-E9BF-4F9C-87C4-5BE27620D95A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33939624-18219ACE-E9BF-4F9C-87C4-5BE27620D95A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5e4306ef7868408566c6986022396e0f175207a4
P2860
Survival advantage with decitabine versus intensive chemotherapy in patients with higher risk myelodysplastic syndrome: comparison with historical experience.